484 related articles for article (PubMed ID: 22931381)
1. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
AlMahri A; Holgersson J; Alheim M
Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
[TBL] [Abstract][Full Text] [Related]
2. A flow cytometric crossmatch test for simultaneous detection of antibodies against donor lymphocytes and endothelial precursor cells.
Alheim M; Johansson SM; Hauzenberger D; Grufman P; Holgersson J
Tissue Antigens; 2010 Mar; 75(3):269-77. PubMed ID: 20070600
[TBL] [Abstract][Full Text] [Related]
3. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
Rose ML; Smith JD
Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
[TBL] [Abstract][Full Text] [Related]
5. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.
Chen G; Sequeira F; Tyan DB
Hum Immunol; 2011 Oct; 72(10):849-58. PubMed ID: 21791230
[TBL] [Abstract][Full Text] [Related]
6. Modified solid-phase alloantibody detection for improved crossmatch prediction.
Wahrmann M; Hlavin G; Fischer G; Marinova L; Schwaiger E; Hörl WH; Zlabinger GJ; Körmöczi GF; König F; Böhmig GA
Hum Immunol; 2013 Jan; 74(1):32-40. PubMed ID: 23073293
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
Wahrmann M; Bartel G; Exner M; Regele H; Körmöczi GF; Fischer GF; Böhmig GA
Transpl Int; 2009 Oct; 22(10):982-9. PubMed ID: 19619171
[TBL] [Abstract][Full Text] [Related]
8. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
Won DI; Jeong HD; Kim YL; Suh JS
Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
[TBL] [Abstract][Full Text] [Related]
11. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
[TBL] [Abstract][Full Text] [Related]
12. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
[TBL] [Abstract][Full Text] [Related]
13. C1q assay for the detection of complement fixing antibody to HLA antigens.
Chen G; Tyan DB
Methods Mol Biol; 2013; 1034():305-11. PubMed ID: 23775744
[TBL] [Abstract][Full Text] [Related]
14. Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies.
Lachmann N; Todorova K; Schulze H; Schönemann C
Transplantation; 2013 Mar; 95(5):694-700. PubMed ID: 23354296
[TBL] [Abstract][Full Text] [Related]
15. The outcome of the endothelial precursor cell crossmatch test in lymphocyte crossmatch positive and negative patients evaluated for living donor kidney transplantation.
Alheim M; AlMahri A; Nilsson J; Tydén G; Holgersson J
Hum Immunol; 2013 Nov; 74(11):1437-44. PubMed ID: 23777925
[TBL] [Abstract][Full Text] [Related]
16. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
Lee H; Han E; Choi AR; Ban TH; Chung BH; Yang CW; Choi YJ; Oh EJ
PLoS One; 2018; 13(11):e0207434. PubMed ID: 30427941
[TBL] [Abstract][Full Text] [Related]
18. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
19. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]